{"id":18314,"date":"2025-11-24T08:28:17","date_gmt":"2025-11-24T08:28:17","guid":{"rendered":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/2025\/11\/24\/bayer-aktie-mit-kurssprung-gerinnungshemmer-asundexian-mit-positiven-studienergebnissen\/"},"modified":"2025-11-24T08:28:17","modified_gmt":"2025-11-24T08:28:17","slug":"bayer-aktie-mit-kurssprung-gerinnungshemmer-asundexian-mit-positiven-studienergebnissen","status":"publish","type":"post","link":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/2025\/11\/24\/bayer-aktie-mit-kurssprung-gerinnungshemmer-asundexian-mit-positiven-studienergebnissen\/","title":{"rendered":"Bayer: Aktie mit Kurssprung, Gerinnungshemmer Asundexian mit positiven Studienergebnissen"},"content":{"rendered":"<p>Bayer-CEO Bill Anderson ben\u00f6tigt in der Pharmasparte dringend einen neuen Umsatzbringer. Der Gerinnungshemmer Asundexian gibt nach positiven Studienergebnissen Anlass zur Hoffnung.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bayer-CEO Bill Anderson ben\u00f6tigt in der Pharmasparte dringend einen neuen Umsatzbringer. Der Gerinnungshemmer Asundexian gibt nach positiven Studienergebnissen Anlass zur Hoffnung.<\/p>\n","protected":false},"author":1,"featured_media":18315,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-18314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts\/18314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/comments?post=18314"}],"version-history":[{"count":0,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts\/18314\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/media\/18315"}],"wp:attachment":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/media?parent=18314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/categories?post=18314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/tags?post=18314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}